8-K current report · filed Nov 16, 2026

Oscar Health, Inc. (OSCR) 8-K Current Report: November 16, 2026

Item 5.02OSCR overview

Short answer

Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on November 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board expanded from 8 to 11 directors with appointments of Tomer Cohen, Eric Larsen, and Rajat Taneja effective November 13, 2026.

Oscar Health, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Board expanded from 8 to 11 directors with appointments of Tomer Cohen, Eric Larsen, and Rajat Taneja effective November 13, 2026
  • Independent directors add product, healthcare, private-equity, AI, cybersecurity, and global technology expertise
  • Committee coverage strengthened: Cohen joins Compensation, Taneja joins Audit and Nominating and Corporate Governance
  • Director compensation includes $70,000 annual board retainers, committee fees, and $200,000 initial and annual RSU grants
  • Eric Larsen’s senior-advisor role at Thrive Capital, Oscar’s majority stockholder, creates a relevant governance relationship despite NYSE independence designation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Oscar Health, Inc. 8-K filings

Get the next OSCR 8-K as it lands

Follow OSCR for push alerts, or ask the research agent what this filing means.